Euphorbiasteroid reverses P-glycoprotein-mediated multi-drug resistance in human sarcoma cell line MES-SA/Dx5

Phytotherapy Research

Volumn 24, Issue 7, 2010, Pages 1042-1046

  Choi, Jung Sook ^a   Kang, Nam Sook ^a   Min, Yong Ki ^a   Kim, Seong Hwan ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Euphorbiasteroid; Multi drug resistance; P glycoprotein

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CYCLOSPORIN A; DOXORUBICIN; ETOPOSIDE; EUPHORBIA EXTRACT; EUPHORBIASTEROID; GLYCOPROTEIN P; PACLITAXEL; UNCLASSIFIED DRUG; VERAPAMIL; VINBLASTINE;

ARTICLE; BAYES THEOREM; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG SENSITIVITY; DRUG STRUCTURE; DRUG TRANSPORT; ENZYME ACTIVITY; EUPHORBIA; HUMAN; HUMAN TISSUE; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; MULTIDRUG RESISTANCE; PROTEIN TRANSPORT; SARCOMA CELL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BAYES THEOREM; CELL LINE, TUMOR; DITERPENES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EUPHORBIA; FEMALE; HUMANS; MODELS, CHEMICAL; P-GLYCOPROTEIN; PHENYLACETATES; SARCOMA; UTERINE NEOPLASMS;

EUPHORBIA LATHYRIS;

EID: 77954513679     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3073     Document Type: Article

References (32)

1. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. 1999. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39: 361-398.
2. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. 2003. P-glycoprotein: from genomics to mechanism. Oncogene 22: 7468-7485.
3. Appendino G, Della Porta C, Conseil G, Sterner O, Mercalli E, Dumontet C, Di Pietro A. 2003. A new P-glycoprotein inhibitor from the caper spurge (Euphorbia lathyris). J Nat Prod 66: 140-142.
4. Bender A, Mussa HY, Glen RC, Reiling S. 2004. Molecular similarity searching using atom environments, informationbased feature selection, and a naïve Bayesian classifier. J Chem Inf Comput Sci 44: 170-178.
5. Choi CH. 2005. ABC transporters as multi-drug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int 5: 30.
6. Crivori P, Reinach B, Pezzetta D, Poggesi I. 2006. Computational models for identifying potential P-glycoprotein substrates and inhibitors. Mol Pharm 3: 33-44.
7. Engi H, Vasas A, Rédei D, Molnár J, Hohmann J. 2007. New MDR modulators and apoptosis inducers from Euphorbia species. Anticancer Res 27: 3451-3458. (Pubitemid 47607575)
8. Ferreira MJ, Gyémánt N, Madureira AM, Molnár J. 2005. Inhibition of P-glycoprotein transport activity in a resistant mouse lymphoma cell line by diterpenic lactones. Anticancer Res 25: 3259-3262. (Pubitemid 41105198)
9. Ford JM. 1995. Modulators of multidrug resistance. Preclinical studies. Hematol Oncol Clin North Am 9: 337-361.
10. Fu LW, Deng ZA, Pan QC, Fan W. 2001. Screening and discovery of novel MDR modifiers from naturally occurring bisbenzylisoquinoline alkaloids. Anticancer Res 21: 2273-2280. (Pubitemid 33054386)
11. Garrigues A, Nugier J, Orlowski S, Ezan E. 2002. A high-throughput screening microplate test for the interaction of drugs with P-glycoprotein. Anal Biochem 305: 106-114.
12. Gosland MP, Lum BL, Sikic BI. 1989. Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells. Cancer Res 49: 6901-6905.
13. Harker WG, Sikic BI. 1985. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA. Cancer Res 45: 4091-4096. (Pubitemid 16224856)
14. Hartwell JL. 1969. Plants used against cancer. A survey. Lloydia 32: 78-107.
15. Hohmann J, Molnár J, Rédei D, Evanics F, Forgo P, Kálmán A, Argay G, Szabó P. 2002. Discovery and biological evaluation of a new family of potent modulators of multidrug resistance: reversal of multi-drug resistance of mouse lymphoma cells by new natural jatrophane diterpenoids isolated from Euphorbia species. J Med Chem 45: 2425-2431.
16. Kartner N, Riordan JR, Ling V. 1983. Cell surface P-glycoprotein associated with multi-drug resistance in mammalian cell lines. Science 221: 1285-1288.
17. Kerr KM, Sauna ZE, Ambudkar SV. 2001. Correlation between steady-state ATP hydrolysis and vanadate-induced ADP trapping in Human P-glycoprotein. Evidence for ADP release as the rate-limiting step in the catalytic cycle and its modulation by substrates. J Biol Chem 276: 8657-8664.
18. Kessel D. 1989. Exploring multidrug resistance using rhodamine 123. Cancer Commun 1: 145-149.
19. Madureira AM, Spengler G, Molnár A, Varga A, Molnár J, Abreu PM, Ferreira MJ. 2004. Effect of cycloartanes on reversal of multi-drug resistance and apoptosis induction on mouse lymphoma cells. Anticancer Res 24: 859-864.
20. Muñoz-Martínez F, Lu P, Cortés-Selva F, Pérez-Victoria JM, Jiménez IA, Ravelo AG, Sharom FJ, Gamarro F, Castanys S. 2004. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multi-drug resistance. Cancer Res 64: 7130-7138.
21. Ozols RF, Cunnion RE, Klecker RW Jr, Hamilton TC, Ostchega Y, Parrillo JE, Young RC. 1987. Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients. J Clin Oncol 5: 641-647.
22. Rosenberg MF, Velarde G, Ford RC, Martin C, Berridge G, Kerr ID, Callaghan R, Schmidlin A, Wooding C, Linton KJ, Higgins CF. 2001. Repacking of the transmembrane domains of P-glycoprotein during the transport ATPase cycle. EMBO J 20: 5615-5625.
23. Spivey AC, Weston M, Woodhead S. 2002. Celastraceae sesquiterpenoids: biological activity and synthesis. Chem Soc Rev 31: 43-59.
24. Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. 2006. Targeting multi-drug resistance in cancer. Nat Rev Drug Discov 5: 219-234.
25. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y. 1981. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41: 1967-1972. (Pubitemid 11114605)
26. Valente C, Ferreira MJ, Abreu PM, Gyémánt N, Ugocsai K, Hohmann J, Molnár J. 2004. Pubescenes, jatrophane diterpenes, from Euphorbia pubescens, with multi-drug resistance reversing activity on mouse lymphoma cells. Planta Med 70: 81-84.
27. van der Valk P, van Kalken CK, Ketelaars H, Broxterman HJ, Scheffer G, Kuiper CM, Tsuruo T, Lankelma J, Meijer CJ, Pinedo HM, Scheper RJ. 1990. Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule. Ann Oncol 1: 56-64.
28. Wang YH, Li Y, Yang SL, Yang L. 2005. Classification of Substrates and Inhibitors of P-Glycoprotein Using Unsupervised Machine Learning Approach. J Chem Inf Model 45: 750-757.
29. Weaver JL, Szabo G Jr, Pine PS, Gottesman MM, Goldenberg S, Aszalos A. 1993. The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter. Int J Cancer 54: 456-461.
30. Wesolowska O, Paprocka M, Kozlak J, Motohashi N, Dus D, Michalak K. 2005. Human sarcoma cell lines MES-SA and MES-SA/Dx5 as a model for multi-drug resistance modulators screening. Anticancer Res 25: 383-389. (Pubitemid 40470134)
31. Wesolowska O, Wisniewski J, Duarte N, Ferreira MJ, Michalak K. 2007. Inhibition of MRP1 transport activity by phenolic and terpenic compounds isolated from Euphorbia species. Anticancer Res 27: 4127-4133.
32. Xia X, Maliski EG, Gallant P, Rogers D. 2004. Classification of kinase inhibitors using a Bayesian model. J Med Chem 47: 4463-4470.